Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05004792 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Dermoscopy Augmented Histology Trial, a Randomized Controlled Trial

Study acronym: DAHT-RCT
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jun 13, 2026 to Aug 13, 2026
    • Study completion pushed from Jun 1, 2027 to Dec 13, 2027
    • Primary completion date: Dec 1, 2026 to Dec 13, 2026
    v4
  2. Primary completion date: Dec 2025 to Dec 1, 2026v3 Show 7 more changesShow less
    • Start date: Apr 2025 to Jun 13, 2026
    • Primary endpoints: 1 to 2
    • Enrollment target: 300 to 258
    • Study completion date: Dec 2026 to Jun 1, 2027
    • Eligibility criteria revised
    • Secondary endpoints: 13 to 9
    • Study description expanded, about 2,106 words
  3. Primary completion date: Oct 2021 to Dec 2025v2 Show 8 more changesShow less
    • Start date: Aug 2021 to Apr 2025
    • Primary endpoint revised
    • Study completion date: Oct 2021 to Dec 2026
    • Eligibility criteria revised
    • Secondary endpoints: 1 to 13
    • Study description expanded, about 206 words
    • Publications: 7 to 9
    • Study title expanded, about 4 words
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Herlev Hospital
27 trials monitored
See 3 trials at risk
Melanoma
1,092 trials monitored
See 60 trials at risk
Pathologists provide the current gold standard in skin lesion diagnostics, most often primarily based on the interpretation of histological slides. Still, it has been suggested that pathologists' diagnostic accuracy and confidence could be improved if they gained access to additional clinical information and in-vivo clinical and dermoscopic images of melanocytic tumors. This study examines the effect of digital training for pathologists in interpreting dermoscopic and clinical skin tumor images. This study aims to evaluate the impact of dermoscopy training on pathologists' assessment of melanoma-suspected skin lesions. Data collection of DAHT cases: Department of plastic surgery, Herlev hospital, year 2020-2021, DAHT platform: Made in 2021-2023 by Melatech, Consensus agreement: Four dermatopathologists assess all DAHT cases, year 2023-2024 Enrollment of pathologists: Randomization and assessment DAHT cases, year 2026.
Trial Details
NCT Number NCT05004792
Lead Sponsor Herlev Hospital
Conditions
(from sponsor)		 Melanoma, Pigmented Lesions
Related terms Melanoma
Enrollment 258 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov